Product Information
TEMAZEPAM 22.5 MG CAPSULE is a generic product labeled by SpecGx LLC, priced at $1.5492 per EA under NDC 00406995903. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the temazepam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
22.5 mg/1
Manufacturer
SpecGx LLCNDC
00406995903
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TEMAZEPAMApproval Type
New Drug (NDA)
FDA Application
NDA018163FDA Approved
Before 1982
TE Code
AB
On Market Since
2/23/2010
Pharmacological Classes
Price Statistics
The NADAC for TEMAZEPAM 22.5 MG CAPSULE has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 68.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5492 per EA |
|---|---|
| All-time high | $5.9577 (Mar 11, 2015) |
| All-time low | $1.1572 (Nov 20, 2024) |
| 52-week high | $2.0272 |
| 52-week low | $1.5147 |
| Median price | $3.2062 |
| Average price | $3.3840 |
| Largest weekly change | +81.6% (Mar 23, 2022) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
SpecGx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
temazepam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TEMAZEPAM 22.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 22.5 MG CAPSULE, manufactured by SpecGx LLC, is $1.5492 per EA (NDC 00406995903), effective Sep 30, 2026.
How has the price of TEMAZEPAM 22.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMAZEPAM 22.5 MG CAPSULE has declined 68.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TEMAZEPAM 22.5 MG CAPSULE?
Since Nov 28, 2013, the NADAC for TEMAZEPAM 22.5 MG CAPSULE has ranged from a low of $1.1572 (Nov 20, 2024) to a high of $5.9577 (Mar 11, 2015), with a median of $3.2062 per EA.
Are there cheaper alternatives to TEMAZEPAM 22.5 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TEMAZEPAM 22.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TEMAZEPAM 22.5 MG CAPSULE?
TEMAZEPAM 22.5 MG CAPSULE (NDC 00406995903) is labeled by SpecGx LLC, and CMS classifies it as a generic product.